We are live on ! Find out more
AIP

Arrowpoint Investment Partners Portfolio holdings

AUM $113M
1-Year Est. Return 73.91%
This Fund
S&P 500
This Quarter Est. Return
+27.01%
1 Year Est. Return
+73.91%
3 Year Est. Return
5 Year Est. Return
10 Year Est. Return
AUM
$100M
AUM Growth
-$12.5M
Cap. Flow
-$21.9M
Cap. Flow %
-21.93%
Top 10 Hldgs %
52.15%
Holding
138
New
74
Increased
1
Reduced
3
Closed
59

Sector Composition

Rank Sector Weight
1 Financials 17.53%
2 Consumer Discretionary 7.92%
3 Technology 7.73%
4 Healthcare 6.98%
5 Communication Services 5.29%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
ENPH icon
51
Enphase Energy
ENPH
$5.45B
$426K 0.43%
+12,038
New +$447K
XLU icon
52
State Street Utilities Select Sector SPDR ETF
XLU
$22.4B
$401K 0.4%
+9,200
New +$389K
NVDA icon
53
NVIDIA
NVDA
$5.31T
$366K 0.37%
1,960
-25,416
-93% -$4.43M
MDGL icon
54
Madrigal Pharmaceuticals
MDGL
$11.8B
$363K 0.36%
+792
New +$295K
ARGX icon
55
argenx
ARGX
$55.2B
$358K 0.36%
+486
New +$320K
IONS icon
56
Ionis Pharmaceuticals
IONS
$9.57B
$357K 0.36%
+5,463
New +$267K
KC
57
Kingsoft Cloud Holdings
KC
$3.55B
$298K 0.3%
+20,004
New +$290K
VSTM icon
58
Verastem
VSTM
$600M
$257K 0.26%
+29,087
New +$216K
EWC icon
59
iShares MSCI Canada ETF
EWC
$6.49B
$253K 0.25%
+5,000
New +$240K
COGT icon
60
Cogent Biosciences
COGT
$7.12B
$231K 0.23%
+16,098
New +$191K
VTI icon
61
Vanguard Morningstar Total Stock Market ETF
VTI
$692B
$230K 0.23%
+700
New +$221K
RVMD icon
62
Revolution Medicines
RVMD
$43.9B
$205K 0.2%
+4,389
New +$172K
ORCL icon
63
Oracle
ORCL
$431B
$203K 0.2%
+723
New +$184K
RGEN icon
64
Repligen
RGEN
$9.15B
$203K 0.2%
+1,520
New +$185K
PTCT icon
65
PTC Therapeutics
PTCT
$6.17B
$202K 0.2%
+3,291
New +$171K
EWS icon
66
iShares MSCI Singapore ETF
EWS
$1.15B
$201K 0.2%
+7,100
New +$196K
XLI icon
67
State Street Industrial Select Sector SPDR ETF
XLI
$34.6B
$170K 0.17%
+1,100
New +$167K
EWY icon
68
iShares MSCI South Korea ETF
EWY
$25.4B
$120K 0.12%
+1,500
New +$112K
ESPR
69
DELISTED
Esperion Therapeutics
ESPR
$107K 0.11%
+40,487
New +$78.3K
HUYA
70
Huya Inc
HUYA
$556M
$105K 0.1%
+31,413
New +$103K
FXI icon
71
iShares China Large-Cap ETF
FXI
$4.34B
$90.5K 0.09%
+2,200
New +$85K
VTYX
72
DELISTED
Ventyx Biosciences
VTYX
$83.5K 0.08%
+26,858
New +$71.2K
GUTS icon
73
Fractyl Health
GUTS
$111M
$55.6K 0.06%
+35,000
New +$45.4K
TSHA icon
74
Taysha Gene Therapies
TSHA
$1.87B
$39.9K 0.04%
+12,200
New +$34.5K
IYR icon
75
iShares US Real Estate ETF
IYR
$4.51B
$38.8K 0.04%
+400
New +$38.5K

Similar funds

Arrowpoint Investment Partners's Q3 2025 Portfolio in Review

As of Q3 2025, Arrowpoint Investment Partners held 138 positions worth $100M, down 11% from $113M the previous quarter. Its ten largest holdings account for 52% of the portfolio.

Arrowpoint Investment Partners withdrew a net $21.9M in Q3 2025, closing 59 positions and reducing 3 holdings. Its most notable exit was State Street SPDR S&P 500 ETF Trust, an estimated $10.7M position sold in full.

By sector, the portfolio is most concentrated in Financials at 18% of assets, up from 5.9% a quarter earlier, followed by Consumer Discretionary and Technology.

Against the trend, Arrowpoint Investment Partners opened a new position in Aegon worth $15.4M.

  • Arrowpoint Investment Partners's largest Q3 2025 buy was Aegon: 1,928,379 shares worth $15.4M.
  • Arrowpoint Investment Partners added most to Ryanair in Q3 2025, an estimated $113K increase.
  • Arrowpoint Investment Partners's biggest Q3 2025 reduction was Sea Limited, cutting an estimated $7.83M.
  • Arrowpoint Investment Partners fully exited State Street SPDR S&P 500 ETF Trust in Q3 2025, selling an estimated $10.7M.
  • Arrowpoint Investment Partners's ten largest holdings make up 52% of its $100M portfolio in Q3 2025.
  • Arrowpoint Investment Partners opened 74 new positions and closed 59 in Q3 2025.
  • Arrowpoint Investment Partners's portfolio value fell 11% quarter-over-quarter to $100M.

Based on Arrowpoint Investment Partners's 13F filing for Q3 2025, filed 14 Nov 2025.